Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity

Obesity Surgery

Volumn 8, Issue 3, 1998, Pages 253-260

  Näslund, Erik ^a   Backman, Lars ^a   Holst, Jens Juul ^c   Theodorsson, Elvar ^d   Hellström, Per M ^b  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Gastric inhibitory peptide glucose dependent insulinotropic peptide; Glucagon like peptide 1; Glucose; Insulin; Jejunoileal bypass surgery; Morbid obesity; Weight loss

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE; GLUCOSE; INSULIN; PEPTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; JEJUNOILEAL BYPASS; MEAL; NORMAL HUMAN; OBESITY; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HUMANS; INSULIN; INTESTINE, SMALL; JEJUNOILEAL BYPASS; MIDDLE AGED; PEPTIDE FRAGMENTS; POSTPRANDIAL PERIOD; PROTEIN PRECURSORS; TIME FACTORS; WEIGHT LOSS;

EID: 0031874016     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089298765554449     Document Type: Article

References (31)

1. Sjöström L. Mortality of severely obese subjects. Am J Clin Nutr 1992; 55: S516-23.
2. Drent ML, van der Veen EA. Endocrine aspects of obesity. Netherlands J Med 1995; 47: 127-36.
3. Ørskov C. Glucagon-like peptide-1, a new hormone of the entero-insular axis. Diabetologia 1992; 35: 701-11.
4. Lauritsen KB, Moody AJ, Christensen KC et al. Gastric inhibitory peptide (GIP) and insulin release after small-bowel resection in man. Scand J Gastroenterol 1981; 16: 417-23.
5. Payne J, DeWind L. Surgical treatment of obesity. Am J Surg 1969; 118: 141-7.
6. Sarson D, Scopinaro N, Bloom S. Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity. Int J Obes 1981; 5: 471-80.
7. Holst JJ. Glucagon-like peptide-1: a newly discovered gastrointestinal hormone. Gastroenterology 1994; 107: 1848-55.
8. Rehfeld JF, Juhl E, Quaade F. Effect of jejunoileostomy on glucose and insulin metabolism in ten obese patients. Metabolism 1970; 19: 529-38.
9. Kral JG, Sjöström L, Gustafsson A. Effects of jejunoileal bypass on serum lipoproteins and glucose tolerance in severely obese patients. Eur J Clin Invest 1980; 10: 363-7.
10. Gutniak M, Ørskov C, Holst JJ et al. Antidiabetogenic effect of glucagon-like peptide-1 (7-36amide) in normal subjects and patients with diabetes mellitus. N Engl J Med 1992; 236: 1316-22.
11. Backman L, Hallberg D. Small-intestinal length. An intraoperative study in obesity. Acta Chir Scand 1974; 140: 57-63.
12. Backman L. The rate of weight loss after intestinal bypass operations for obesity. Acta Chir Scand 1975; 141: 424-30.
13. Scott HW, Sandstead HH, Brill AB et al. Experience with a new technique of intestinal bypass in the treatment of obesity. Ann Surg; 174: 560-72.
14. Ørskov C, Rabenhøj L, Kofod H et al. Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes 1994; 43: 535-9.
15. Ranganath LR, Beety JM, Morgan LM et al. Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 1996; 38: 916-9.
16. Service FJ, Rizza RA, Westland RE et al. Gastric inhibitory peptide in obesity and diabetes mellitus. J Clin Endocrinol Metab 1984; 58: 1133-40.
17. Jones IR, Owens DR, Luzio SD et al. Obesity is associated with increased post-prandial GIP-levels which are not reduced by dietary restriction and weight loss. Diabetes Metab 1989; 15: 11-22.
18. Hvidberg A, Toft-Nielsen MT, Hilsted J et al. Effect of glucagon-like peptide-1 (proglucagon 78-107 amide) on hepatic glucose production in healthy man. Metabolism 1994; 43: 104-108.
19. Holst JJ. GLP-1 in NIDDM. Diabetic Medicine 1996; 13: S156-60.
20. Grybäck P, Näslund E, Hellström PM et al. Gastric emptying of solids in humans: improved evaluation by Kaplan-Meier plots with special reference to obesity and gender. Eur J Nucl Med 1996; 23: 1562-7.
21. Sylvan A, Sjölund B, Janunger KG. Favourable long-term results with the end-to-side jejunoileal bypass. Obes Surg 1995; 5: 357-63.
22. Pories WJ, Swansson MS, MacDonald KG. Who would have thought it? An operation proves to be the most effective therapy for adult onset diabetes mellitus. Ann Surg 1995; 222: 339-52.
23. Näslund E, Melin I, Grybäck P et al. Reduced food intake after jejunoileal bypass. A possible association with prolonged gastric emptying and changed gut hormone patterns. Am J Clin Nutr 1997; 66: 26-32.
24. Robinson P, Folstein MF, McHugh P. Reduced caloric intake following small bowel bypass surgery: a systematic study of possible causes. Psychol Med 1979; 9: 37-52.
25. Fenyö G, Backman L, Hallberg D. Morphological changes of the small intestine following jejuno-ileal shunt in obese subjects. Acta Chir Scand 1976; 142: 154-9.
26. Buchan AMJ, Pederson RA, Koop I et al. Morphological and functional alterations to a subgroup of regulatory peptides in human pancreas and intestine after jejunoileal bypass. Int J Obes 1993; 17: 109-13.
27. Nauck MA, Heimesaat MM, Ørskov C et al. Preserved incretin activity of GLP-1 (7-36 amide) but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 1993; 91: 301-7.
28. Nauck MA, Niedereichholz U, Ettler R et al. Glucagon-like peptide-1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 1997; 273: E981-8.
29. Willms B, Werner J, Holst JJ et al. Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36 amide) in type 2 (non-insulin dependent) diabetic patients. J Clin Endocrinol Metab 1996; 81: 327-32.
30. Näslund E, Grybäck P, Hellström PM et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes 1997; 48: 387-92.
31. Kellum JM, Kuemmerle JF, O'Dorisio TM et al. Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty. Ann Surg 1990; 211: 763-70.